Thierry Jean
Directeur Général chez Cerep, Inc.
Profil
Thierry Jean is the founder of Eurofins-Cerep SA, which was founded in 1989.
He served as the Chairman & Chief Executive Officer from 2011 to 2014.
Dr. Jean is currently the Chairman & Chief Executive Officer at Anceris SA, Cerep, Inc., and Cerep Ltd.
He has also held positions as a Director at SpinX Technologies SA and as a Principal at the National Center For Scientific Research and Leem Recherche.
Dr. Jean holds a doctorate degree from the University of Maryland and an undergraduate degree from Université Paris 1 Panthéon-Sorbonne.
Postes actifs de Thierry Jean
| Sociétés | Poste | Début |
|---|---|---|
| Cerep, Inc. | Directeur Général | 14/03/2011 |
| Cerep Ltd. | Directeur Général | 14/03/2011 |
Anceris SA
 Anceris SA Pharmaceuticals: MajorHealth Technology Anceris SA specializes in developing therapeutic products for treatment of cancer. The company was founded in February 2000 and is headquartered in Paris, France. | Directeur Général | 23/10/2007 |
Anciens postes connus de Thierry Jean
| Sociétés | Poste | Fin |
|---|---|---|
| EUROFINS CEREP | Directeur Général | 13/10/2014 |
SpinX Technologies SA
 SpinX Technologies SA Medical SpecialtiesHealth Technology SpinX designs and develops products which exploit its innovative adaptive microfluidics technology. The firm's platform offers a fully integrated solution which drastically reduces manual work, while avoiding complex and costly robotics, and can be used in a wide variety of applications, from drug discovery to consumer diagnostics. The reduced consumption of samples, reagents and other consumables enables increased throughput and results in significant cost savings. Additionally, the platform enables sophisticated interleaved liquid handling and detection steps not possible with other systems. SpinX is an international, multidisciplinary - but highly focused - team with world-class competences in microfludics, opto-electronics, molecular biology, biochemistry and software. The founders of SpinX Technologies, Bart Van de Vyver, Ph.D and Piero Zucchelli, Ph.D., worked together for 10 years on various research projects at CERN, the European Organization for Nuclear Research. They have conducted leading-edge academic research in particle physics and instrumentation and managed numerous state-of-the-art research projects. The SpinX Board of Directors and Advisory Board include experts from Europe and the United States, from a variety of backgrounds and disciplines covering drug discovery, diagnostics, microfluidics and physics. | Directeur/Membre du Conseil | 12/08/2010 |
| Leem Recherche | Corporate Officer/Principal | - |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Formation de Thierry Jean
| University of Maryland | Doctorate Degree |
| Université Paris 1 Panthéon-Sorbonne | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EUROFINS CEREP | Commercial Services |
| Entreprise privées | 6 |
|---|---|
Anceris SA
Anceris SA Pharmaceuticals: MajorHealth Technology Anceris SA specializes in developing therapeutic products for treatment of cancer. The company was founded in February 2000 and is headquartered in Paris, France. | Health Technology |
SpinX Technologies SA
SpinX Technologies SA Medical SpecialtiesHealth Technology SpinX designs and develops products which exploit its innovative adaptive microfluidics technology. The firm's platform offers a fully integrated solution which drastically reduces manual work, while avoiding complex and costly robotics, and can be used in a wide variety of applications, from drug discovery to consumer diagnostics. The reduced consumption of samples, reagents and other consumables enables increased throughput and results in significant cost savings. Additionally, the platform enables sophisticated interleaved liquid handling and detection steps not possible with other systems. SpinX is an international, multidisciplinary - but highly focused - team with world-class competences in microfludics, opto-electronics, molecular biology, biochemistry and software. The founders of SpinX Technologies, Bart Van de Vyver, Ph.D and Piero Zucchelli, Ph.D., worked together for 10 years on various research projects at CERN, the European Organization for Nuclear Research. They have conducted leading-edge academic research in particle physics and instrumentation and managed numerous state-of-the-art research projects. The SpinX Board of Directors and Advisory Board include experts from Europe and the United States, from a variety of backgrounds and disciplines covering drug discovery, diagnostics, microfluidics and physics. | Health Technology |
| Leem Recherche | |
Centre National de la Recherche Scientifique
Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Government |
| Cerep, Inc. | |
| Cerep Ltd. |
